BRPI0412697A - composições farmacêuticas que apresentam um revestimento expansìvel - Google Patents

composições farmacêuticas que apresentam um revestimento expansìvel

Info

Publication number
BRPI0412697A
BRPI0412697A BRPI0412697-1A BRPI0412697A BRPI0412697A BR PI0412697 A BRPI0412697 A BR PI0412697A BR PI0412697 A BRPI0412697 A BR PI0412697A BR PI0412697 A BRPI0412697 A BR PI0412697A
Authority
BR
Brazil
Prior art keywords
expandable coating
pharmaceutical compositions
expandable
coating
pharmaceutical
Prior art date
Application number
BRPI0412697-1A
Other languages
English (en)
Inventor
Irukulla Srinivas
Akhilesh Ashok Dixit
Pallempalli Venkata Silv Reddy
Billa Praveen Reddy
Mailatur Sivaraman Mohan
Kodipyaka Ravinder
Vijay Nasare
Edward D Pergament
Original Assignee
Reddys Lab Inc Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Inc Dr filed Critical Reddys Lab Inc Dr
Publication of BRPI0412697A publication Critical patent/BRPI0412697A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS QUE APRESENTAM UM REVESTIMENTO EXPANSìVEL". Uma forma de dosagem farmacêutica contendo um ativo farmacêutico que não é estável na presença de ácido compreende um núcleo contendo o ativo e um desintegrante, um revestimento expansível ao redor do núcleo, e um revestimento entérico ao redor do revestimento expansível.
BRPI0412697-1A 2003-07-17 2004-07-16 composições farmacêuticas que apresentam um revestimento expansìvel BRPI0412697A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN580CH2003 2003-07-17
IN1064CH2003 2003-12-30
US56370704P 2004-04-20 2004-04-20
PCT/US2004/022910 WO2005009410A2 (en) 2003-07-17 2004-07-16 Pharmaceutical compositions having a swellable coating

Publications (1)

Publication Number Publication Date
BRPI0412697A true BRPI0412697A (pt) 2006-10-03

Family

ID=34108415

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412697-1A BRPI0412697A (pt) 2003-07-17 2004-07-16 composições farmacêuticas que apresentam um revestimento expansìvel

Country Status (12)

Country Link
EP (1) EP1651193A2 (pt)
JP (1) JP2007524646A (pt)
KR (1) KR20060065632A (pt)
AU (1) AU2004259226B2 (pt)
BR (1) BRPI0412697A (pt)
CA (1) CA2532310A1 (pt)
HR (1) HRP20060016A2 (pt)
IL (1) IL173053A0 (pt)
MX (1) MXPA06000577A (pt)
NO (1) NO20060786L (pt)
NZ (1) NZ544608A (pt)
WO (1) WO2005009410A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050147663A1 (en) * 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
FR2878159B1 (fr) * 2004-11-24 2008-10-17 Flamel Technologies Sa Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire
AR054358A1 (es) * 2005-05-13 2007-06-20 Combino Pharm Sl Formulaciones que contienen pantoprazol libre de acido y sus sales
CA2614526A1 (en) * 2005-07-11 2006-10-12 Nycomed Danmark Aps Benzimidazole formulation
JP2009523784A (ja) 2006-01-16 2009-06-25 ジュビラント・オルガノシス・リミテッド 酸不安定化合物の安定な医薬製剤およびその製造方法
MY173730A (en) 2008-03-11 2020-02-18 Takeda Pharmaceuticals Co Orally-disintegrating solid preparation
EP2319504A1 (en) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical solid dosage form
US20130216617A1 (en) * 2010-06-29 2013-08-22 Cadila Healthcare Limited Pharmaceutical compositions of (r)-lansoprazole
ES2689906T3 (es) * 2012-08-09 2018-11-16 Dynamis Therapeutics, Inc. Meglumina para reducir los niveles altos de triglicéridos
JP6856326B2 (ja) * 2016-07-15 2021-04-07 富士化学工業株式会社 腸放出粒子組成物
KR101907116B1 (ko) 2016-07-25 2018-10-11 한미약품 주식회사 에스오메프라졸, 또는 약학적으로 허용 가능한 그의 염을 포함하는, pH-의존성 약물 방출 특성이 개선된 제형
KR101877350B1 (ko) * 2016-10-28 2018-08-09 한미약품 주식회사 에스오메프라졸 함유 복합 캡슐제 및 그 제조방법
JP6336651B1 (ja) * 2016-12-15 2018-06-06 大原薬品工業株式会社 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤
US20200368219A1 (en) * 2017-09-28 2020-11-26 Hanmi Pharm. Co., Ltd. Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
JP7026510B2 (ja) * 2018-01-11 2022-02-28 株式会社Ｓｃｒｅｅｎホールディングス 印刷物、読取装置、読取方法、印刷方法、および印刷装置
JP7652406B2 (ja) * 2019-09-30 2025-03-27 備前化成株式会社 多糖類を含有する固形経口組成物
CN111728124A (zh) * 2020-07-08 2020-10-02 江苏宏远药业有限公司 一种安全性较高的食品级白色素
JP7808937B2 (ja) * 2020-09-10 2026-01-30 沢井製薬株式会社 顆粒、顆粒を含む製剤、顆粒の製造方法、及び顆粒を含む製剤の製造方法
US12409145B2 (en) 2020-09-10 2025-09-09 Sawai Pharmaceutical Co., Ltd. Granule, preparation containing the granule, production method of the granule, and production method of preparation containing the granule
CN115998705A (zh) * 2022-08-26 2023-04-25 苏州弘森药业股份有限公司 一种非布司他纳米包合物的制备方法
CN117136996A (zh) * 2023-10-10 2023-12-01 河南工业大学 用于水相体系中坚果包被的包衣膜及其制备方法、应用
NL2037901B1 (en) * 2024-06-07 2026-01-08 Merdury Biopharmaceutical Corp Oral peptide drug structure and manufacturing method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US341338A (en) * 1886-05-04 Blind
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US5882715A (en) * 1995-06-20 1999-03-16 Pharma-Vinci A/S Method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method
ES2236628T3 (es) * 1995-09-21 2005-07-16 Pharma Pass Ii Llc Composicion farmaceutica que contiene un omeprazol labil de acido, y procedimiento para su preparacion.
US6296876B1 (en) * 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
US6500459B1 (en) * 1999-07-21 2002-12-31 Harinderpal Chhabra Controlled onset and sustained release dosage forms and the preparation thereof
US6635206B1 (en) * 2000-05-03 2003-10-21 The Board Of Trustees Of The University Of Illinois Method of manufacturing improved corn zein resin films, sheets, and articles
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo

Also Published As

Publication number Publication date
AU2004259226A1 (en) 2005-02-03
CA2532310A1 (en) 2005-02-03
WO2005009410A2 (en) 2005-02-03
AU2004259226B2 (en) 2009-09-24
KR20060065632A (ko) 2006-06-14
IL173053A0 (en) 2006-06-11
MXPA06000577A (es) 2006-07-03
NO20060786L (no) 2006-04-10
WO2005009410A3 (en) 2005-05-19
EP1651193A2 (en) 2006-05-03
JP2007524646A (ja) 2007-08-30
HRP20060016A2 (en) 2006-02-28
NZ544608A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
BRPI0108478B8 (pt) composição nutritiva contendo substancias pré-bióticas
BRPI0412029A (pt) formulações para microprojeções revestidas contendo contra-ìons não-voláteis
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
BR0109925A (pt) Composição de revestimento para mascaramento de paladar
BR0317275A (pt) Liberação controlada de uma substância ativa em um ambiente de gordura alta
HUP0302991A3 (en) Isoxazoles and their use as inhibitors of erk and pharmaceutical compositions containing the compounds
SE9500422D0 (sv) New oral pharmaceutical dosage forms
BR0109943A (pt) Composições farmacêuticas
PA8529501A1 (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7."
AR046970A1 (es) Esteres de fosfato de florfenicol
UY27352A1 (es) Formulacion de iniciacion rápida
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
MX2007006212A (es) Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular.
AR023789A1 (es) Composicion farmaceutica en forma unitaria que contiene acido acetilsalicilico y hidrogenosulfato de clopidogrel
BR0202491A (pt) Forma de dosagem de núcleo macio, de revestimento frágil
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
BRPI0415053B8 (pt) inibidor de glicoproteína-p, método para preparar o mesmo e composição farmacêutica que compreende o mesmo
BRPI0417585A (pt) composição pregabalina
ES2196620T3 (es) Formulacion de liberacion prolongada que contiene venlafaxina.
BRPI0414305A (pt) sistema de liberação de drogas por via oral
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2143 DE 31/01/2012.